Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Tuberculosis

Free Subscription Articles published in J Antimicrob Chemother Retrieve available abstracts of 36 articles: HTML format

Single Articles

April 2008
1. MARTIN A , Panaiotov S, Portaels F, Hoffner S, et al
   The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
   J Antimicrob Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   December 2007
2. KARAKOUSIS PC , Williams EP, Bishai WR
   Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis.
   J Antimicrob Chemother. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
3. COHEN K , van Cutsem G, Boulle A, McIlleron H, et al
   Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.
   J Antimicrob Chemother. 2007;.
   PubMed     Related articles    Abstract available
   
   
   November 2007
4. MARTIN A , Cubillos-Ruiz A, Von Groll A, Del Portillo P, et al
   Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
   J Antimicrob Chemother. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
5. DE STEENWINKEL JE , van Vianen W, Ten Kate MT, Verbrugh HA, et al
   Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
   J Antimicrob Chemother. 2007;60:1064-73.
   PubMed     Related articles    Abstract available
   
   
   August 2007
6. SALIU OY , Crismale C, Schwander SK, Wallis RS, et al
   Bactericidal activity of OPC-67683 against drug-tolerant Mycobacterium tuberculosis.
   J Antimicrob Chemother. 2007;.
   PubMed     Related articles    Abstract available
   
   
   July 2007
7. ARAGON LM , Garrigo M, Moreno C, Espanol M, et al
   Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
   J Antimicrob Chemother. 2007;.
   PubMed     Related articles    Abstract available
   
   
   June 2007
8. TANEJA NK , Tyagi JS
   Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
   J Antimicrob Chemother. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
9. BANAIEE N , Jacobs WR, Ernst JD
   LspA-independent action of globomycin on Mycobacterium tuberculosis.
   J Antimicrob Chemother. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
10. CYNAMON M , Sklaney MR, Shoen C
    Gatifloxacin in combination with rifampicin in a murine tuberculosis model.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
11. JADAUN GP , Agarwal C, Sharma H, Ahmed Z, et al
    Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
12. SRIRAM D , Yogeeswari P, Dinakaran M, Thirumurugan R, et al
    Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. AFANAS'EV MV , Ikryannikova LN, Il'ina EN, Sidorenko SV, et al
    Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
14. BARROSO PA , Marco JD, Calvopina M, Kato H, et al
    A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. WANG JY , Lee LN, Lai HC, Wang SK, et al
    Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. FORTUN J , Martin-Davila P, Molina A, Navas E, et al
    Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
    J Antimicrob Chemother. 2007;59:794-8.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    March 2007
17. CHAN RC , Hui M, Chan EW, Au TK, et al
    Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    February 2007
18. UMUBYEYI AN , Rigouts L, Shamputa IC, Fissette K, et al
    Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
19. RIBERA E , Azuaje C, Lopez RM, Domingo P, et al
    Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
20. RAMON-GARCIA S , Martin C, De Rossi E, Ainsa JA, et al
    Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. SHARMA R , Muttil P, Yadav AB, Rath SK, et al
    Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. AMARAL L , Martins M, Viveiros M
    Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps.
    J Antimicrob Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
23. BYRNE ST , Denkin SM, Zhang Y
    Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
24. MARTIN A , Portaels F, Palomino JC
    Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
25. LONG MC , Allan PW, Luo MZ, Liu MC, et al
    Evaluation of 3-deaza-adenosine analogues as ligands for adenosine kinase and inhibitors of Mycobacterium tuberculosis growth.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
26. LOPEZ-CORTES LF , Ruiz-Valderas R, Ruiz-Morales J, Leon E, et al
    Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen.
    J Antimicrob Chemother. 2006;58:1017-23.
    PubMed     Related articles    Abstract available
    
    
    October 2006
27. FRIEDLAND G , Khoo S, Jack C, Lalloo U, et al
    Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
28. BARCO P , Cardoso RF, Hirata RD, Leite CQ, et al
    pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
29. GARCIA-CONTRERAS L , Sethuraman V, Kazantseva M, Godfrey V, et al
    Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
30. WADE MM , Zhang Y
    Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    July 2006
31. DAVIES GR , Khoo SH, Aarons LJ
    Optimal sampling strategies for early pharmacodynamic measures in tuberculosis.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
32. PARK IN , Hong SB, Oh YM, Kim MN, et al
    Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
33. MITCHISON DA
    Clinical development of anti-tuberculosis drugs.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    June 2006
34. MARTIN A , Takiff H, Vandamme P, Swings J, et al
    A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
35. PANDEY R , Khuller GK
    Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model.
    J Antimicrob Chemother. 2006;57:1146-52.
    PubMed     Related articles    Abstract available
    
    
    March 2006
36. ARAGON LM , Navarro F, Heiser V, Garrigo M, et al
    Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.
    J Antimicrob Chemother. 2006;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Boehringer Ingelheim and Pfizer.

Amedeo is a Bernd Sebastian Kamps website.    Design: